Gene · 1999
Papers2,176
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,176
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ELF3 drives glioblastoma multiforme progression through the regulation of MXRA8 expression. | Sci Rep | 2026 | 41922512 | PubTator, text mining | PubMed |
| Urine-Based Approaches for Screening, Diagnosis, and Surveillance of Urothelial Carcinoma. | J Pers Med | 2026 | 41893002 | PubTator, text mining | PubMed |
| The histone acylation network: emerging therapeutic targets for remodeling the epigenetic landscape in pancreatic ductal adenocarcinoma. | Cell Oncol (Dordr) | 2026 | 41874858 | PubTator, text mining | PubMed |
| Epigenetic regulation under light and temperature fluctuations: chromatin remodeling and transcriptional memory in plants. | Plant Cell Rep | 2026 | 41860716 | PubTator, text mining | PubMed |
| Identification of alterations of immunometabolism associated with Pompe disease. | Cell Mol Life Sci | 2026 | 41840212 | PubTator, text mining | PubMed |
| Subtype-specific dependencies and therapeutic opportunities in small cell lung cancer. | Sci Adv | 2026 | 41824576 | PubTator, text mining | PubMed |
| Selective inhibition of ALDH1A3 impedes breast cancer growth and metastasis by blocking ALDH1A3-driven transcriptional programs. | iScience | 2026 | 41797928 | PubTator, text mining | PubMed |
| CLDN7: Epithelial gatekeeper from physiology to pathology‑roles in cancer and epithelial‑related diseases (Review). | Int J Mol Med | 2026 | 41789662 | PubTator, text mining | PubMed |
| Identification of key macrophage-related genes in systemic sclerosis-associated interstitial lung disease based on single-cell and bulk transcriptomic data. | PLoS One | 2026 | 41785251 | PubTator, text mining | PubMed |
| Miglustat: a first-in-class enzyme stabilizer for cipaglucosidase alfa for the treatment of late-onset Pompe disease. | Ther Adv Rare Dis | 2026 | 41769220 | PubTator, text mining | PubMed |
| Genomic Subtypes and Computational Biomarkers in Non-Muscle-Invasive Bladder Cancer Guiding Optimal Timing of Radical Cystectomy and BCG Response Prediction. | Genes (Basel) | 2026 | 41751537 | PubTator, text mining | PubMed |
| Immunogenicity in Fabry Disease: Current Issues, Coping Strategies, and Future Directions. | Biomedicines | 2026 | 41751242 | PubTator, text mining | PubMed |
| Nasopharyngeal Carcinoma at the Virology Precision Oncology Nexus: Decoding Molecular Alterations for Early Intervention and Therapeutic Innovation. | Biomolecules | 2026 | 41750326 | PubTator, text mining | PubMed |
| Photoprotection for Skin Cancer: What's New. | Cancers (Basel) | 2026 | 41749887 | PubTator, text mining | PubMed |
| Gastric-Type Cervical Adenocarcinoma: Clinicopathologic Features, Molecular Landscape, and Therapeutic Challenges. | J Pers Med | 2026 | 41745365 | PubTator, text mining | PubMed |
| LncRNA SLC16A1-AS1 cooperates with NSUN2 to stabilize GRP78 mRNA via m5C modification in gastric cancer. | iScience | 2026 | 41727188 | PubTator, text mining | PubMed |
| Sprint performance changes in adolescent athletes following a 6-week elastic resistance training program: a preliminary field study. | BMC Sports Sci Med Rehabil | 2026 | 41724971 | PubTator, text mining | PubMed |
| Short-Term Intensive Avalglucosidase Alfa Regimen in Late-Diagnosed Infantile Pompe Disease: A Case Report. | Reports (MDPI) | 2026 | 41718282 | PubTator, text mining | PubMed |
| Genome and drug resistance analysis of Mycobacterium abscessus complex on tropical islands in China. | Front Microbiol | 2026 | 41716264 | PubTator, text mining | PubMed |
| Physical Fitness and Physical Function in Patients With Fabry Disease: A Cross-Sectional Multicentre Study. | J Cachexia Sarcopenia Muscle | 2026 | 41709110 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1999/papers?page=2